# Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy

> **NCT03391856** · PHASE2,PHASE3 · TERMINATED · sponsor: **Peking University People's Hospital** · enrollment: 15 (actual)

## Conditions studied

- Thrombocytopenia
- Stem Cell Transplant Complications

## Interventions

- **DRUG:** N-acetyl-L-cysteine (NAC)
- **OTHER:** supportive therapy

## Key facts

- **NCT ID:** NCT03391856
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-01
- **Primary completion:** 2018-12-30
- **Final completion:** 2018-12-30
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** protocol changed
- **Last updated:** 2020-09-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03391856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03391856, "Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03391856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*